Treatment of Diabetes Flashcards

1
Q

What are the main ways that insulin is produced

A

Animal procine or animal bovine

Human recombinant

Insulin analogues - where one or two amino acids in an insulin molecule have been changed which allows the modification of the pharmacokinetic properties

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Name the 6 main insulin catagories and drug examples of each

A

Ultrafast acting

Rapid acting - Nororapid

Short acting - Actrapid, Humulin S

Intermediate acting - isophane insulin. Given overnight to prevent hyperglycaemia

Long acting and very long acting - insulin degludec, insulin glargine. Allow low level of insulin in body

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Name some adverse effects of insulin therapy

A

Hypoglycaemia

Hyperglycaemia

Lipodystrophy - lipohypertrophy or lipoatrophy

Painful injections

Insulin allergies - mainly to preservatives

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Name some drugs that are used in the treatment of type 2 diabetes

A

Metformin (biguanides)

Sulphonylureas

Thiazolidinediones - pioglitazone

DPP4 inhibitors

Gliflozins (SGLT2s)

GLP1 analogues - exenatide, liraglutide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the target HbA1c level for type 2 diabetics

A

HbA1c of 6.5 to 7.5%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Describe how metformin works

A

Decreased insulin resistance -> increased glucose uptake by tissues

Decreased hepatic glucose production

Limits weight gain

Decreased risk of CVS events

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Name some side effects of metformin treatment

A

GI symtpoms

Vit B12 deficiency

Lactic acidosis - rare

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Describe how sulphonylureas work and what their side effects are

A

Sulphonylureas stimulate beta-cells to release insulin

They decrease microvascular risks associated with diabetes

Side effects: weight gain and hypoglycaemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Name some sulphonylureas

A

Gliclazide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Describe how thiazolidinediones work in treating diabetes

A

Thiazolidinediones increase insulin sensitivity in muscle and aidpose and decrease hepatic glucose output

They bind to and activate PPARs

Are rarely used - used in combination with other agents

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Name a thiazolidinedione and what the concerns regarding its use are

A

Pioglitazone

Concerns regarding weight gain, fluid retention and HF. Risk of bladder cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Describe how gliflozins work

A

Gliflozins selectively inhibit SGLT2 in the PCT to inhibit glucose reabsorption in the PCT and so increase glucose excretion

Can be used as an add on

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How does GLP-1 help to treat diabetes

A

GLP-1 is released from intestinal L-cells and causes:

  • Increased insulin and decreased glucagon secretion
  • Increased sateity
  • Decreased gastric emptying
  • Increased glucose uptake by muscles
  • Decreased glucose production by the liver
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Name some GLP-1 agonists

A

Exenatide

Liraglutide

Lixisenatide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Name some ADRs with the use of GLP-1 agonists

A

GI symptoms - nausea, loose stools, diarrhoea, gastroesophageal reflux

Painful injection

Risk of pancreatitis and pancreatic carcinoma though NICE and FDA found no evidence of pancreatitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Describe how gliptins/DPP4 inhibitors work and what their side effects are

A

DPP4 antagonists inhibt DPP4 activity to increase post-prandial active GLP-1 concentrations

Side effects include GI symptoms and pancreatitis. Low risk of hypoglycaemia

E.g. sitagliptin, vildagliptin, linagliptin